Crohn Disease
📧 Sign up to get email alerts when something new happens for Crohn Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-10-03Clinical Trial Update: A Study to Evaluate Adverse Events and Change in Disease Activity in Participants Between 18 to 75 Years of Age Treated With Intravenous (IV) Infusion and Subcutaneous (SC) Injections of ABBV-154 for Moderately to Severely Active Crohn's Disease [Phase 2]
Phase 2 study evaluating adverse events and changes in disease activity in adults with moderately to severely active Crohn's disease treated…
-
CLINICAL_TRIALS trial_result · 2024-10-02Clinical Trial Update: Addressing Disability Effectively With Psychosocial Telemedicine [NA]
This update notes the completion of a clinical trial evaluating psychosocial telemedicine to address disability in Crohn's disease.
-
CLINICAL_TRIALS trial_result · 2024-10-01Clinical Trial Update: Evaluation of Local Co-administration of Autologous ADIpose Derived Stromal Vascular Fraction With Microfat for Refractory Perianal CROHN's Fistulas. [Phase 2]
Phase 2 trial evaluating the local co-administration of autologous adipose-derived stromal vascular fraction with microfat for refractory pe…
-
CLINICAL_TRIALS trial_result · 2024-10-01Clinical Trial Update: Transcutaneous VNS to Treat Pediatric IBD [NA]
A completed clinical trial evaluating transcutaneous vagus nerve stimulation for pediatric inflammatory bowel disease. The study included ch…
-
FDA approval · 2024-09-27FDA Approved: OTULFI — Original Application (Fresenius Kabi USA, LLC)
FDA approved OTULFI (ustekinumab-aauz) from Fresenius Kabi USA, LLC, as an original application. OTULFI is a monoclonal antibody targeting I…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-09-24Clinical Trial Update: A Study to Evaluate the Long-term Safety and Efficacy of Deucravacitinib in Participants With Crohn's Disease or Ulcerative Colitis [Phase 2]
Phase 2 trial update evaluating the long-term safety and efficacy of deucravacitinib in participants with Crohn's disease or ulcerative coli…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Study to Assess Efficacy and Safety of Cx601, Adult Allogeneic Expanded Adipose-derived Stem Cells (eASC) for the Treatment of Complex Perianal Fistula(s) in Participants With Crohn's Disease (CD) [Phase 3]
This Phase 3 trial evaluated Cx601 (darvadstrocel), an allogeneic adipose-derived stem cell therapy, for complex perianal fistulas in Crohn'…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: ENhanced Recovery in CHildren Undergoing Surgery [Phase 3]
A Phase 3 clinical trial assessing Enhanced Recovery in children undergoing surgery for inflammatory bowel disease has completed.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Correlation Between RISANKIZUMAB's Trough Levels, Clinical and Biological Remission in Moderate to Severe Crohn's Disease: a Retrospective Multicentric Study
A retrospective multicenter study evaluating the relationship between risankizumab trough levels and clinical/biological remission in adults…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Digital Behavioral Interventions in Inflammatory Bowel Disease [NA]
A completed clinical trial conducted at Montefiore Medical Center evaluated digital behavioral interventions for patients with Crohn's disea…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: A Study in Pregnant Women With Chronic Inflammatory Diseases Treated With Cimzia (Certolizumab Pegol) [Phase 1]
A Phase 1 clinical trial evaluating certolizumab pegol (Cimzia) in pregnant women with chronic inflammatory diseases has completed and poste…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: A Dietary Intervention Study on the Microbiome in Crohn's Disease Patients [NA]
This ClinicalTrials.gov update reports the completion of a dietary intervention study examining the gut microbiome in Crohn's disease patien…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Beta-Hydroxybutyrate Feasibility Treating IBD [Phase 1, Phase 2]
A Phase 1/2 feasibility trial assessing beta-hydroxybutyrate for Crohn's disease and inflammatory bowel disease; recruitment is ongoing.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: FAPi-PET Imaging of in Vivo Fibrosis in Inflammatory Bowel Disease Patients [Phase 2]
Phase 2 clinical trial evaluating FAPi-PET imaging of in vivo fibrosis in inflammatory bowel disease patients is currently recruiting.
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Infliximab Proactive Drug Monitoring in the Pediatric IBD Population
Clinical trial update on proactive drug monitoring with infliximab in pediatric inflammatory bowel disease. The study status is ACTIVE_NOT_R…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Effectiveness and Tolerance of IV vs SC Biological Drugs in Gastrointestinal Diseases
A clinical trial comparing intravenous versus subcutaneous administration of biological drugs for inflammatory bowel diseases is currently r…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Pharmacokinetic Infliximab Data in Pediatric Crohn's Disease [Phase 4]
Phase 4 clinical trial assessing pharmacokinetics of infliximab in pediatric Crohn's disease is currently recruiting.
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Semi-elemental Versus Polymeric EEN in the Preoperative Optimization for Patients with CD [NA]
A clinical trial update notes a study comparing semi-elemental vs polymeric enteral nutrition for preoperative optimization in Crohn's disea…
-
CLINICAL_TRIALS research · 2024-09-04Clinical Trial Update: Subcutaneous Interval Lengthening of Vedolizumab for Economic Research [Phase 4]
A Phase 4 clinical trial is evaluating longer-interval subcutaneous administrations of vedolizumab for economic research in inflammatory bow…
-
CLINICAL_TRIALS research · 2024-08-29Clinical Trial Update: A Microdose Trial Investigating Binding of [68Ga]Ga-DOTA-CYS-ATH001 in Healthy Subjects and Different Patient Groups. [EARLY_Phase 1]
Early-phase microdose clinical trial evaluating binding of the radiotracer [68Ga]Ga-DOTA-CYS-ATH001 in healthy volunteers and patients with …
-
CLINICAL_TRIALS trial_result · 2024-08-27Clinical Trial Update: IUS Predicts Upadacitinib Efficacy in Patients With Moderate to Severe Crohn's Disease：a Prospective Study
A prospective study suggests intestinal ultrasound predictors may forecast the efficacy of upadacitinib in patients with moderate-to-severe …
-
FDA approval · 2024-08-26FDA Approved: ADALIMUMAB-RYVK — Supplemental Application (Quallent Pharmaceuticals Health LLC)
The FDA approved a supplemental application for ADALIMUMAB-RYVK, a biosimilar to adalimumab, submitted by Quallent Pharmaceuticals Health LL…
-
CLINICAL_TRIALS research · 2024-08-26Clinical Trial Update: Mother-to-Infant Transfer of Bacteriome, Fungome, Virome, and Metabolome in Health and Crohn's Disease
This clinical trial update describes mother-to-infant transfer of the bacteriome, fungome, virome, and metabolome in health and in Crohn's d…
-
CLINICAL_TRIALS research · 2024-08-22Clinical Trial Update: Safety and Efficacy of Fecal Microbiota Transplantation [NA]
A multicondition clinical trial evaluating fecal microbiota transplantation for various conditions; the study is currently recruiting.
-
CLINICAL_TRIALS research · 2024-08-15Clinical Trial Update: Investigation of VAP-1 Expression and Tissue Blood Flow by PET-MRI in Patients With Crohn's Disease
This clinical trial investigates VAP-1 expression and tissue blood flow using PET-MRI in patients with Crohn's disease. Enrollment is curren…